The human rotavirus vaccine Rotarix™ in infants: An integrated analysis of safety and reactogenicity

An integrated analysis of safety and reactogenicity data was undertaken for 28 randomized, placebo-controlled, double-blind Phase II and III trials (DBRCTs) of the oral live-attenuated human rotavirus vaccine, Rotarix™ (GlaxoSmithKline Vaccines). Healthy infants aged 6–20 wk received 2 or 3 doses of...

Descripción completa

Detalles Bibliográficos
Autores principales: Buyse, Hubert, Vinals, Carlota, Karkada, Naveen, Han, Htay Htay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181014/
https://www.ncbi.nlm.nih.gov/pubmed/24047799
http://dx.doi.org/10.4161/hv.26476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181014/
https://www.ncbi.nlm.nih.gov/pubmed/24047799
http://dx.doi.org/10.4161/hv.26476

Ejemplares similares